Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
KURA
#2592
Kura Oncology, Inc.
8.9
8
USD
-1.75%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-1.75%
Changement Mensuel
+3.58%
Evolution sur 6 mois
-13.49%
Changement Annuel
+49.67%
Clôture Précédente
9.1
4
Open
8.9
3
Bid
Ask
Low
8.9
0
High
8.9
9
Volume
118
Marchés
Actions des Marchés US
Soins de Santé
KURA
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
66.21 M
66.61 M
68.44 M
76.14 M
80.75 M
88.33 M
—
Valuation ratios
Enterprise value
1.84 B
846.18 M
782.04 M
1.14 B
488.44 M
778.36 M
2.42 B
Price to earnings ratio
—
—
-5.94
-7.38
-4.31
-3.27
-12.57
Price to sales ratio
—
—
—
—
13.93
13.5
—
Price to cash flow ratio
—
—
-7.33
-9.01
5.59
-14.22
3.14
Price to book ratio
—
—
1.92
2.83
1.81
5.23
6.49
Enterprise value to EBITDA ratio
—
-6.74
—
—
-2.4
-2.54
—
Profitability ratios
Return on assets %
-0.14
-0.24
-0.3
-0.34
-0.23
-0.38
-0.4
Return on equity %
-0.15
-0.26
-0.32
-0.38
-0.42
-1.6
-1.14
Return on invested capital %
-4 731.27
-4 261.24
-4 669.95
-4 398.28
-2 520.1
-1 522.22
-1 640.21
Gross margin %
—
100
—
—
100
100
400
Operating margin %
—
62.01 K
—
—
-358.55
-449.94
-1 817.07
EBITDA margin %
—
59.68 K
—
—
-380.39
-460.23
-1 860.26
Net margin %
—
61.54 K
—
—
-322.89
-412.95
-1 663.99
Liquidity ratios
Quick ratio
—
—
—
—
—
6.05
—
Current ratio
24.49
23.26
18.56
12.26
9.46
6.06
25.4
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
-0
—
—
0.09
0.09
0.1
Solvency ratios
Debt to assets ratio
0.01
0.01
0.02
0.02
0.01
0.01
0.06
Debt to equity ratio
0.01
0.01
0.02
0.02
0.02
0.06
0.15
Long term debt to total assets ratio
0.01
0.01
0.02
0.02
0.01
0.01
0.04
Long term debt to total equity ratio
0.01
0.01
0.02
0.02
0.02
0.06
0.12
Per share metrics
Operating cash flow per share
—
—
-1.64
-1.7
1.56
-0.73
-0.73
EBIT per share
—
—
—
—
-2.24
-3.46
-3.47
EBITDA per share
—
—
—
—
-2.38
-3.54
-3.55
Total debt per share
—
—
0.14
0.13
0.11
0.11
0.44
Cash per share
—
—
6.54
5.79
8.44
7.61
28.61
Net current asset value per share
—
—
6.66
5.91
8.64
8.08
30.99
Tangible book value per share
—
—
6.27
5.43
4.8
1.99
12.41
Working capital per share
—
—
6.3
5.42
7.73
6.75
26.02
Book value per share
—
—
6.27
5.43
4.8
1.99
12.41
Nouvelles
Kura Oncology: Commercialization In AML Presents Asymmetric Upside (NASDAQ:KURA)
Mizuho abaisse l’objectif de cours de Kura Oncology en raison de ventes retardées
UBS abaisse l’objectif de cours de Kura Oncology à 15$
UBS lowers Kura Oncology stock price target to $15 on launch data
Kura Oncology à la conférence Leerink : perspectives d’expansion
Kura Oncology at Leerink Global Healthcare Conference: Strategic Expansion Insights
Kura Oncology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:KURA) 2026-03-06
Citizens réitère sa recommandation sur Kura Oncology après un lancement solide
Citizens reiterates Kura Oncology stock rating on strong launch
Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates
Le BPA de Kura Oncology Inc a manqué les attentes de 0,66$, le CA en dessous des prévisions
Kura Oncology Inc earnings missed by $0.66, revenue fell short of estimates